CompoSecure closes $2.1B refinancing; issues $900M 5.625% notes due 2033, new $1.2B term loan and $400M revolver

GPGI, Inc.

Refinanced ~$2.1B aggregate principal debt following Jan 13, 2026 combination with Husky Technologies.
Issued $900M 5.625% Senior Secured Notes due 2033; semi-annual interest starts Aug 1, 2026.
Entered new $1.2B term loan facility maturing 2033 and $400M revolving credit facility maturing 2031.
Proceeds used to redeem $1.0B of Husky's 9.000% Senior Secured Notes for ~$1.04B and repay existing credit agreement.
Terminated existing Credit Agreement; no early termination penalties or prepayment premium incurred.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

GPGI, Inc. entered into Indenture with U.S. Bank Trust Company, National Association valued at $900.0 million aggregate principal amount of 5.625% Senior Secured Notes due 2033 (effective 2026-01-14).

Action: entry
Agreement: notes offering
Counterparty: U.S. Bank Trust Company, National Association
Value: $900.0 million aggregate principal amount of 5.625% Senior Secured Notes due 2033
Effective: 2026-01-14

Exact text from the filing

The 2033 Notes were issued pursuant to an indenture (the " Indenture "), dated as of January 14, 2026 (the " Closing Date "), among the Issuer, the Company, the subsidiary guarantors party thereto from time to time (together with the Company, the " Guarantors ") and U.S. Bank Trust Company, National Association, as trustee (the " Trustee ") and as notes collateral agent (the " Notes Collateral Agent ").

View on SEC.gov

281 material agreements filed in the last 30 days. Browse all material agreements →

GPGI, Inc. filing history →

Source: SEC EDGAR

accession 0000950142-26-000161

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.